Lung disease, antibodies and other unresolved issues in immune globulin therapy for antibody deficiency

Clinical and Experimental Immunology

Volumn 157, Issue SUPPL. 1, 2009, Pages 12-16

  Cunningham Rundles, C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody deficiency; Immune globulin; Infection; Lung disease

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; MACROLIDE; MUCOLYTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; AUTOIMMUNE DISEASE; CHRONIC LUNG DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; CONFERENCE PAPER; CORTICOSTEROID THERAPY; GASTROINTESTINAL DISEASE; GRANULOMATOSIS; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOTHERAPY; PNEUMONIA; PRIORITY JOURNAL; PULMONARY REHABILITATION; SUBSTITUTION THERAPY; TREATMENT OUTCOME;

B-LYMPHOCYTE SUBSETS; BIOLOGICAL MARKERS; HALF-LIFE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LUNG DISEASES; MALE; OPPORTUNISTIC INFECTIONS;

EID: 67149137844     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03952.x     Document Type: Conference Paper

References (29)

1. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002 109 : 1001 4.
2. Quinti I, Soresina A, Agostini C et al. Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration. J Clin Immunol 2008 28 : 263 7.
3. Liese JG, Meschievitz CK, Harzer E et al. Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr Infect Dis J 1997 16 : 1038 44.
4. Quartier P, Debre M, De Blic J et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999 134 : 589 96.
5. Olinder-Nielsen AM, Granert C, Forsberg P, Friman V, Vietorisz A, Bjorkander J. Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up. Scand J Infect Dis 2007 39 : 44 50. (Pubitemid 46277147)
6. Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 1999 104 : 1031 6.
7. Kainulainen L, Nikoskelainen J, Vuorinen T, Tevola K, Liippo K, Ruuskanen O. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999 159 : 1199 204.
8. Quinti I, Soresina A, Spadaro G et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007 27 : 308 16.
9. Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987 1 : 1075 7.
10. Orange JS, Hossny EM, Weiler CR et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006 117 (Suppl. 4 S525 53.
11. Eijkhout HW, van Der Meer JW, Kallenberg CG et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001 135 : 165 74.
12. de Gracia J, Vendrell M, Alvarez A et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 2004 4 : 745 53.
13. Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 2008 128 : 314 21.
14. Chapel H, Lucas M, Lee M et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008 112 : 277 86.
15. Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep 2001 1 : 421 9.
16. Carsetti R, Rosado MM, Donnanno S et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005 115 : 412 7.
17. Wehr C, Kivioja T, Schmitt C et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008 111 : 77 85.
18. Waldmann TA, Strober W. Metabolism of immunoglobulins. Prog Allergy 1969 13 : 1 110.
19. Ballow M, Berger M, Bonilla FA et al. Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). Vox Sang 2003 84 : 202 10.
20. Berger M, Cunningham-Rundles C, Bonilla FA et al. Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases. J Clin Immunol 2007 27 : 503 9.
21. Ochs HD, Pinciaro PJ. Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases. J Clin Immunol 2004 24 : 309 14.
22. Berger M. A multicenter, prospective, open label, historically controlled clinical trial to evaluate efficacy and safety in primary immunodeficiency diseases (PID) patients of Flebogamma 5% DIF, the next generation of Flebogamma. J Clin Immunol 2007 27 : 628 33.
23. Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007 7 : 715 25.
24. Akilesh S, Christianson GJ, Roopenian DC, Shaw AS. Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 2007 179 : 4580 8.
25. Sachs UJ, Socher I, Braeunlich CG, Kroll H, Bein G, Santoso S. A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter. Immunology 2006 119 : 83 9.
26. Mikolajczyk MG, Concepcion NF, Wang T et al. Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Clin Diagn Lab Immunol 2004 11 : 1158 64.
27. Vanaudenaerde BM, Vos R, Meyts I et al. Macrolide therapy targets a specific phenotype in respiratory medicine: from clinical experience to basic science and back. Inflamm Allergy Drug Targets 2008 7 : 279 87.
28. Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2009 1 : CD001288.
29. Bhowmik A, Chahal K, Austin G, Chakravorty I. Improving mucociliary clearance in chronic obstructive pulmonary disease. Respir Med 2009 103 : 496 502.